ANZ Vasculitis Society, '26 Vasculitis Wkshop host

Highlights of #vasculitismelbourne #IVW26 presented by @ANZVASC and @thelimbicrheum. A great summary by @drdavidliew highlighting some of the interesting work in the "non-AAV" vasculitides. Also excellent talks from Dr Limy Wong and Dr Irene Ruderman - chaired by @hollylhutton

Register: thelimbic.com/nephrology/ivw… Missed the International Vasculitis Workshop or want a recap? Join our post-workshop webinar for an expert round-up of key clinical updates & their impact on practice. @anzvasc @KitchingLab @hollylhutton @drdavidliew

Thanks everyone for coming to Melbourne for the 22nd International Vasculitis Workshop #vasculitis26 It's been great❗ Safe travels ✈️ and see you in Istanbul 🇹🇷 for #vasculitis28‼️

@TrishBrady16 @ZoiAn2 @Robsonjo4 @_ERNRITA @ukivas @RAIRDA_org This was a ftf workshop format. Recordings and slides from the main workshop won't be available on line.

@ZoiAn2 @Robsonjo4 @anzvasc @_ERNRITA @ukivas @RAIRDA_org Is the presentation available anywhere online?

Improving longer term management in GCA vasculitis and PMR. @Robsonjo4 is talking about PROMs and their importance at @anzvasc #IVW26 #vasculitis #PROMs @_ERNRITA @ukivas @RAIRDA_org

#vasculitis26 Prof Meg Jardine, an expert in modern and innovative trial methods. Making every patient count in trials of rare diseases. Excellent examples of how vasculitis trials may be conducted in the future.

#vasculitis26 Registries - a pillar of quality, planning and research: Prof Stephen McDonald sharing his insights on 50 years of the ANZ Dialysis and Transplant Registry - ANZDATA.

#vasculitis26 The post afternoon tea sessions on Tuesday: ANCA-associated vasculitis and the lung - new findings and new concepts: Ulrich Specks and next, Ron Falk

Now the floor at @anzvasc belongs to Prof Lorraine Harper. How do viruses impact ANCA associated vasculitis? Do they amplify the damage? #IVW26 #vasculitis @_ERNRITA @ukivas #renalvasculitis

An absolutely fantastic presentation at @anzvasc about cardiovascular morbidity risk in #vasculitis patients. In awe of @TYoungstein and her work on improving the care of us the vasculitis patients. #IVW26 @_ERNRITA @ukivas

And it is time to talk about Kawasaki disease. Thank you Prof Ian Wicks for bringing this pediatric vasculitis and the cardiac disease related to it in the spotlight. @anzvasc #IVW26 @_ERNRITA #vasculitis #kawasakidisease

#vasculitis26 Six new Clinical Trials being presented in the Clinical Trial Session. This one from Xavier Puechal of the FSVG: MAINRITSEG - maintenance therapy in EGPA.

Treatment algorithm of Giant Cell Arteritis: ⁦@anzvasc⁩ #IVW2026 ⁦@DrAkhilX⁩ ⁦@IhabFathiSulima⁩ #MedTwitter

Precision medicine, transplantation what can we learn? Harry Robertson an award winning PHD student is introducing us to this subject at @anzvasc #IVW26 #vasculitis @_ERNRITA

#vasculitis26 Tuesday Plenary Session - Prof Melissa Southey from @SCSMonash on CHIP - including in #vasculitis !

#vasculitis26 A critical question. when to stop treatment in AAV? Peter Merkel leads an interactive panel of Rachel Jones, Shunsuke Furuta and Benjamin Terrier with audience voting.

#vasculitis. Mini-workshop at the 22nd International Vasculitis Workshop. The Melbourne Biomarker Consortium? A way forward for biomarkers in ANCA-associated vasculitis involving the kidney.

Professor Mohammed is now presenting at the 22nd International Vasculitis Workshop in Melbourne — sharing insights on ANCA-associated vasculitis and the latest 2022 ACR/EULAR classifications #vasculitis @anzvasc #raredisease @_ERNRITA @ukivas

#vasculitis26 Dr Karl Gisslander ANCA Serotype or Syndrome - or does it not matter?

#vasculitis26. David Tarlinton on the fundamental reasons why some plasma cells live a very long time - important to vasculitis!

First plenary session of the day at @anzvasc and we are learning about the role of T-cells and B-cells in immunity. Thank you Dr Laura Mackay and Dr David Tarlinton for your fantastic presentations. #VIW26 #vasculitis #raredisease @_ERNRITA